02.09.2022
Prevention
$172,903.00
12 months
Epithelial-Based Diagnostics for Targeted Therapies of VEOIBD
Functional characterization of intestinal epithelial cell-specific genes using patient-derived organoid models can lead to a better understanding of the genetic causes of VEO-IBD and can identify pathways to target with therapeutics not only for VEO-IBD but also for adult CD.